Correction for Hesse et al., Serological Responses to a Norovirus Nonstructural Fusion Protein after Vaccination and Infection

AUTHOR CORRECTION

Volume 23, no. 2, p. 181–183, 2016. Page 182: The following should be added to Acknowledgments. “M.K.E. has an equity interest in Takeda Pharmaceuticals North America through LigoCyte and may potentially benefit from the research results. The terms of this arrangement have been reviewed and approved by Baylor College of Medicine in accordance with its research conflict of interest policies.”